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Abstract
The pharmaceutical industry produces carbon-rich liquid
wastes which have been generally qualified as hazardous. A
significant proportion of these carbon-rich wastes are currently
sent for incineration, although they could be utilised. It was
found that the majority of the liquid wastes investigated in
this study could be used in biological N-removal as carbon
sources for denitrification in domestic wastewater treatment, or
for anaerobic biogas production. The volatile content could be
separated and the solvents re-utilised, the residual toxic organic
compounds could be decomposed by wet oxidation and subse-
quently sent for biological treatment.
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1 Introduction
The pharmaceutical industry is growing worldwide and rep-
resents one of the main components of the chemical industry.
However, increasing production may well be accompanied by
increased amounts of by-products and wastes. Liquid wastes
of high organic content – which make up a high proportion of
them - have been classed as hazardous wastes and are disposed
of mainly by incineration. These so-called process wastewaters
(PWW) are usually aqueous solutions, and, they cannot be dis-
charged directly into municipal sewer systems due to their high
organic content. Simple dilution of these wastes is also prohib-
ited.
A significant proportion of the carbon-rich wastes is currently
sent for incineration, although they could be utilised as a car-
bon source for biological denitrification in domestic wastewater
treatment plants, or for anaerobic biogas production. It would
be possible to separate their volatile content and the solvents
could be re-utilised. Residual toxic organic compounds could
be decomposed by oxidation and sent for biological treatment
afterwards.
So far we have found no reference in the literature [1, 2] to
a detailed study on mixing very large amounts of almost com-
pletely biodegradable effluents with the recalcitrant waste of the
fine chemical and pharmaceutical industry. The research car-
ried out in this area focused firstly on determining the levels
of concentration of the most frequently used pharmaceuticals in
surface waters [3]. The elimination ratio of some compounds
in wastewater treatment plant (WWTP) and in the environment
have been also studied [4,5], and in another paper [6] the authors
try to follow the different processes responsible for the degra-
dation of Carbamazepine, Clofibric Acid, Diclofenac, Ibupro-
fen, Ketoprofen and Naproxen in rivers and in a lake. Bouwer
and coworkers [7] systematically determined the elimination ef-
ficiency (18-100%) of WWTP for 18 pharmaceuticals and per-
sonal care products (PPCPs). Obviously the concentration of the
tested compounds, including some antiseptic agents was in the
100-4000 ng/L range.
The reports on degradation studies did not focus on high con-
centration wastes or the systematic variation of the parameters
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affecting degradation such as the concentration of the pollutant,
bacterial strains, additives and ionic strength.
The literature survey yields information about methods of in-
cinerating these complicated wastes of varying compositions or
mineralizing them in wet oxidation [8].
There are no reports, however, on low cost biological treat-
ment of mother liquors of pharmaceutical origin, which contain
organic and inorganic toxic materials. A comprehensive chemi-
cal analysis of the waste of any pharmaceutical industry is com-
plicated to carry out due to the large number of components and
it is not economically viable in industrial terms (9, 10).
Non-biodegradable waste generated from industrial processes
can be treated by chemical oxidation, wet oxidation or with
Advanced Oxidation Processes (AOP’s) [11]-[14]. The PWWs
generated by pharmaceuticals production often prove to be bio-
logically recalcitrant under the current qualification procedures,
due to their high organic content, molecules with aromatic rings
or chlorine substituents. Therefore, they cannot be discharged
directly into the municipal sewer systems and have to be treated
in situ at the industrial site, or a significant proportion of them
are sent for incineration [15].
A physico-chemical approach for handling these wastewaters
involves separation methods that are based on the different rela-
tive volatilities of the compounds. If the contamination is more
volatile than the water or forms hetero-azeotropes with it, strip-
ping, and various kinds of distillation can be applied success-
fully. These physical-chemical tools have the advantage that
contaminated volatile organic compounds (VOC) can be recov-
ered and reused (16-20). If non-volatile compounds are also
present, the problem requires other tools for example membrane
processes or wet oxidation [20, 21].
The non-volatile organic content of PWWs is very diverse,
some effluents are easily biodegradable, and can be treated with
activated sludge in a diluted solution. However, the wastewa-
ters of pharmaceutical industries often contain toxic compounds
which may inhibit the functioning of biomass even in very small
concentrations. The most frequently used chemical treatment
method for such toxic wastes is wet oxidation, which reduces
the high COD level.
Biological treatment with activated sludge is the most effi-
cient and cost-effective way of cleaning domestic wastewater.
However, biological elimination of concentrated, industrial liq-
uid wastes is not commonly applied, because of the toxic charac-
teristics of the organic pollutants present in high concentrations.
Wastes with high carbon content originating from the chemical
industry usually prove to be toxic/non-biodegradable according
to the currently applied qualification methods, and are therefore
disposed of by expensive and often polluting technologies, e.g.
incineration. On the basis of our preliminary experience we as-
sume that well established investigation of biodegradability and
appropriately designed and improved methods or processes may
lead to the successful treatment of biodegradable pharmaceuti-
cal liquid wastes which contain toxic compounds in high con-
centration [22].
The design and operation of biotechnological processes is
mostly based on the kinetics established by Monod in 1949 [23].
This assumes that a given organic substrate asymptotically sup-
ports the growth of the microorganisms with increasing concen-
tration (see eq. 1. and Fig. 1). However, there also exists the so
called Andrews kinetics ([5] (Fig. 1, Eq. 2), developed for the
biodegradation of “biodegradable, toxic” organic compounds.
 
Fig. 1.
The application of Andrews’ kinetics provides a new ap-
proach for the biological elimination and reuse of liquid wastes
which have been regarded to date as “toxic”. This type of ki-
netics reveals that the biodegradation of organic pollutants is a
highly concentration-dependent process. Therefore, liquid toxic
wastes should be biodegraded at lower concentrations.
Monod kinetics:
µ = µmax · SKS + S (1)
Andrews kinetics:
µ = µmax · S
KS + S + S2K I
(2)
µ = specific growth rate of the biomass (d−1),
µmax =maximum specific growth rate of the biomass
(d−1), S = substrate (biodegradable pollutant) concen-
tration (mg l−1),
KS = half saturation coefficient (mg l−1),
KI = inhibition coefficient (mg l−1)
According to the Andrews model microorganisms can grow
by consuming biodegradable, toxic substrates and that biodegra-
dation is basically enhanced at low substrate concentrations. At
high substrate concentrations, the inhibition and toxicity effects
are expressed. Obviously, the values of the coefficients and, as a
result, the shapes of the curves differ considerably depending on
the nature of the substrate to be biodegraded as well as the type
of biomass carrying out the degradation process.
As substrate concentration dependence is not taken into con-
sideration in most of the common methods used for assess-
Per. Pol. Chem. Eng.4 Hosseini, Arezoo Mohammad et al.
ing biodegradability, liquid wastes which are readily biodegrad-
able at low concentrations may be classified as toxic or non-
biodegradable. The results of the research presented in this pa-
per indicate that liquid chemical wastes, PWWs can be treated
and utilised with an appropriate combination of physical, chem-
ical and biological operations. In order to demonstrate the va-
lidity of our assumption, several real PWWs were investigated
and their COD, TOC, BOD and volatile organic content were
determined, as well as the dependence of BOD on dilution with
domestic wastewater. Based on the results obtained, appropri-
ate combined treatment processes have been developed for the
investigated samples, and the basic operating parameters of the
different technologies (wet oxidation, biological treatment, rec-
tification) have been determined.
2 Experimental
2.1 Wastewaters and their characterization
The process wastewater samples [15] were collected by the
Budapest SewageWorks from the pharmaceutical companies lo-
cated in Budapest, all of which are interested in the sustainable
disposal of their liquid wastes. Each sample originates from a
production technology of a given drug molecule or intermediate.
They were treated as “black boxes”, without detailed chemical
analysis; their volatile organic content, physical and chemical
characteristics, COD, TOC and BOD values were measured, and
their anaerobic digestion and oxidation properties determined.
2.2 Chemical characterization, COD and TOC measure-
ments
COD was determined by the standard dichromate method.
The TOC was determined by a Shimadzu TOC analyzer whose
operation was based on catalytic combustion and non-dispersive
infrared (NDIR) gas analysis. The following parameters were
measured (some of these only for selected PWWs): pH, total
salt content, ammonia, TKN (total Kjeldahl nitrogen), dry or-
ganic material.
2.3 Biodegradation characterization
The behaviour of the PWWs was investigated by aerobic
respirometric tests and anaerobic digestion tests, while toxic-
ity was estimated on the basis of sludge respirometry and batch
digestion experiments were carried out by measuring residual
COD. The aerobic respirometric tests were carried out in a
WTW OxiTop device, measuring the oxygen consumption over
10 days (BOD10). The dilution of the tested PWW was con-
ducted until 800 mg/L oxygen consumption, calculated from
COD values. For dilution two peptone solutions were used as
basis wastewaters in concentrations of 25 and 100 mg/L COD,
which also contained NH4Cl, K2HPO4, KH2PO4, MgCl2 and
CaCl2. Released water from the secondary clarifier of the South-
Pest Wastewater Treatment Plant (WWTP) was used for seed-
ing (seeding was provided by the residual suspended biomass).
Oxygen consumption coupled with nitrification was eliminated
by adding allyl thiourea. In the figures (Figs. 2, 3, 4) with
respirometric curves the oxygen consumption is given in mg/L
units calculated for the non-diluted PWW.
BOD5 was measured according to DIN EN 1899-1, also with
an OxiTop device (Fig. 5.b). Denitrification was tested in anoxic
conditions in a zero gas-space 2.5 L batch reactor. 1.2 g/L acti-
vated sludge was used as the seeding biomass, while the water
of the final aerobic basin of the South-Pest WWTP was used as
the diluting medium. The COD concentration of the investigated
waste was 200 mg/L, the nitrate concentration 400 mg/L. Sam-
ples were withdrawn every 30 minutes over 9 hours and their
nitrate, nitrite and COD values were measured.
2.4 Determination of the volatile organic content
The volatile organic content of the process wastewaters was
measured with a distillation probe and subsequent GC analysis,
where the most common components (methanol, ethanol, ethyl
acetate, acetone, etc.) could be identified and their concentration
determined. In addition, initial batch rectification experiments
were carried out for every PWW. When the batch rectification
resulted in significant COD reduction the PWWs were further
investigated. The PWWs of high VOC were also rectified in
continuous mode in a pilot plant laboratory column of 14 theo-
retical plates.
2.5 Oxidation procedures
The non-basic wastewaters (pH<8) were basified before ox-
idation with a solution of 20% NaOH. The samples were oxi-
dized in 850 ml stainless steel high pressure autoclaves equipped
with magnetic stirrers (rpm 700), at temperatures up to 250˚C
and 50 bar total pressure. After pH adjustments, the wastewater
samples were loaded into the autoclave, pressurized with oxy-
gen and heated to the desired temperature, with total pressure
regulated to 50 bar by refilling the autoclave with oxygen, after
which samples were taken and subsequently analyzed.
3 Results and discussion
The measured parameters and biodegradation characteristic
values of the treated PWWs are summarized in Tables 1 and 2.
The PWWs tested represent a large variety of liquid wastes
of the pharmaceutical industry, thus their organic and inorganic
content were rather diverse (COD range of the investigated sam-
ples: 1096-751800 mg/L). The biodegradability of the samples
also proved to be highly variable (the BOD/COD ratios of the
samples were between 2-96%). Thus, it is reasonable to assume
that these PWWs require different treatment methods for exam-
ple mixing of the well biodegradable waste No. 5227 with waste
No. 4982, which proved to be toxic at any dilutions must be
avoided, as it can hinder the biodegradability of the whole mix-
ture. The treatment has to be preceded by the determination of
the properties of the given PWW, in order to provide sufficient
information for the producing company to be able to properly
decide about its fate.
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Tab. 1. Parameters of tested PWWs
Sample
No.
COD TOC BOD10 Adapt. time Volatile
content
pH TKN NH+4 -N Total salt Efficiency of oxidation
****
mg/L mg/L mg/L days v/v% mg/L mg/L g/L COD
decrease %
TOC
decrease %
4693 117 000 41 200 98418 5.5 2.8 14 30 33
4694 68 000 20 090 24 738 3.5 0.28 14 40 27
4695 80 000 25 070 49 298 1.5 0.9 14 38 27
4982 81 715 23 270 1 838 5.0 0.12 8.4 5874 1215*** 175 49 25
4983
d10x
751 800 208 000 721780 0.5 57* 9 309 9 1.1 15 7
5226 39 750 11 600 36458 0.5 2.6 11 49 34
5227
d3x
80 236 26 580 77358 0.5 4.4 6 67 6.7 - 41 7
600
d5x
525 620 134 700 410665 4.0 32.4** 5 8 2.5
602 1096 437 906 2.0 7 60 55
5691 16 005 8 267 8303 1.0 8 58 54
5692 63 079 24 690 28957 0.0 14 40 33
5693 65 471 19 370 40537 3.5 7 32 28
5797
d10x
178 180 52 850 36883 3.5 1 15.2 0.2 15.8 36 20
6367
d10x
235 220 89 380 141033 2.0 1.4 10 25 5
*
ethanol, ** methanol, *** ammonium chloride, **** 250 ◦C, 50 bar, 5 hours, d3,5,10x means diluted in the given ratio
Tab. 2. Biodegradation characteristics of PWW
Sample
No.
BOD/COD % Denitrification capacity
with respect to COD
Anaerobic digestion effi-
ciency
original after
oxidation
with basis
wastewater
after oxidation
with basis
waste water
4693 84 65 91 80
4694 36 65 66 86
4695 62 81 75 94
4982 2 23 0 34 no no
4983 94 98 94 100 good (∼100%) added in > 5v/v% it is
toxic
5226 92 65 94 93 good (∼100%)
5227 96 89 added in < 10 v/v% it is
digestible
600 78 100 95 100
5692 46 71 91 98
5693 62 74 94 93
5797 21 98 28 100 doubled upon oxidation
(30→60%)
non toxic
good
6367 60 76 90 86
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Tab. 3. Atmospheric rectification (in a column with 14 theoretical plates) results of PWWs
Sample No. 4983 600
Feed composition v/v%
amount L/hour
57 ethanol, 43 water,
0.45
32 methanol, 1 acetone, 67 water
0.37
Reflux ratio 5 3
Location of feed middle of column middle of column
Dist. composition v/v%
amount L/hour
90 ethanol, 10 water
0.28
96 organic
0.13
Bottom am. L/hour
volatile content v/v%
COD mg/L
BOD/COD %
0.17
210 ppm ethanol
2500
95
0.24
1460 ppm methanol
4400
85
Remarks crystalline precipitation in the boiler brown colored bottom product, solution with crystals, sed-
imentation is possible
Based on the measurement results the following observations
were made:
1 PWWs No. 4983 and 600 have high COD contents (751800
mg/L and 525620 mg/L, respectively) deriving basically from
their high volatile (ethanol and methanol) content, which can
be recovered with rectification and reused (see Table 3).
This operation may be necessary as the high ethanol and
methanol content decreases the rate of oxidation and can be
toxic at higher concentrations for anaerobic digestion as well.
The organic content of the bottom product of the rectifica-
tion (which needs further treatment), is very low (COD of
No. 4983: 2500 mg/L and No. 600: 4400 mg/L) compared
to the COD content of the original wastes. Continuous pilot
scale denitrification experiment proved that the PWW with
high ethanol content (No. 4983) can be mixed with domes-
tic wastewater and utilised biologically as an external carbon
source for denitrification without pre-treatment. Economic
considerations should determine which kind of treatment is
more appropriate.
2 Based on respirometric measurements it can be suggested that
PWW No. 4982 without pre-treatment is toxic for biodegra-
dation even having diluted by domestic wastewater (Fig. 2).
As biodegradation without pretreatment is not an option to de-
crease this wastewater (4892) toxicity, it should be oxidized
although it is very corrosive under oxidation conditions be-
cause of its high ammonium chloride content. In this case the
incineration may remain the optimal solution for its disposal.
3 The majority of PWWs are biodegradable (Fig. 3), which
means that the organic content of these wastes can be used as
a carbon source for denitrification in appropriate conditions.
The BOD/COD ratio of sample No. 4695 without pretreat-
ment is 62%. With the wet oxidation pre-treatment this ra-
tio can be raised to 81% (see Table 2), effectively decreas-
ing the amount of the non-biodegradable residue. However
during the pretreatment of the PWW a part of the originally
 
Fig. 2. Oxygen consumption of PWW 4982 (original and oxidized) diluted
with domestic wastewater
 
Fig. 3. Oxygen consumption of PWW 4695 as sole carbon source
biodegradable organics are also oxidized, thus the total biode-
graded amount of organic compounds decreased, that results
in ∼40000 mg/l oxygen consumption instead of the original
50000 mg/L.
The original sample No. 5797 proved to be poorly biodegrad-
able (Fig. 4, the BOD/COD ratio was 21%), however, after
pre-treating the sample with wet oxidation, the biodegradabil-
ity was greatly improved (the BOD/COD ratio increased to
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 Fig. 4. Oxygen consumption of PWW 5797 diluted with domestic wastew-
ater
98%).
 
Fig. 5.a. Oxygen consumption of PWW 5797 diluted with domestic
wastewater in different ratio
 
Fig. 5.b. Oxygen consumption of PWW 4983 diluted with domestic
wastewater in different ratio
Biodegradation of samples No. 5797 and No. 4983 showed
strong concentration-dependence
(Fig. 5.a, 5.b), suggesting that although these wastes are not
biodegradable in high concentration, with appropriate dilu-
tion they can be utilized as external carbon sources for deni-
trification.
4 The wet oxidation efficiency (based on oxidation experiments
conducted for 5 hours at 250oC, 50 bar total pressure, which
means∼10 bar oxygen partial pressure, in a batch reaction) is
diverse, the percentage of COD decrease falls between 8 and
60 (see Table 1). The two lowest conversions were obtained
by the oxidation of the two PWWs with the highest COD val-
ues, due to their high volatile organic solvent content. It was
suggested in point 1 that distillation is needed before using
any other treatment method.
Detailed respirometric investigation clearly verified our as-
sumption that most PWWs are biodegradable at least after di-
lution with domestic wastewater at various ratios (Fig. 5.b).
The exception is PWWs No. 4982 (Fig. 2), which is not
degradable in its original state, but becomes degradable after
oxidation.
On the basis of these results a combined treatment method of
the different PWWs has been developed, resulting in Scheme
1. The scheme summarizes the possible means of treatment
and gives guidelines for choosing the appropriate treatment
method for different PWWs. Two examples demonstrate how
its guidance can be used: Sample No. 4983 can be treated
in two ways: it can be used in denitrification or its volatile
content can be distilled and the distillation residue can sub-
sequently be mixed with domestic wastewater and be treated
with activated sludge. No. 4982 has no volatile content and
is not biodegradable, so it has to be oxidized first, thereafter
it can be biodegraded. The other PWWs are biodegradable
in their original form or at least when diluted with domestic
wastewater.
4 Conclusion
It has been shown that the biological and physico-chemical
co-treatment of PWWs of the pharmaceutical industry can be
effectively accomplished, and the majority of the PWWs tested
proved to be biodegradable when appropriately diluted with do-
mestic wastewater. The exceptions are the PWWs with high
volatile organic solvent content and the toxic ones, with the lat-
ter being lethal for the activated sludge even in high dilution.
These PWWs must not be mixed with the others, but the high
volatile content should be removed by rectification or stripping.
After removing their volatile content, the remaining materials
of low COD are biodegradable and the solvents recovered can
be utilized. The toxic waters require wet oxidation, which does
not have to be carried out to a complete mineralization, it is
enough if the toxic components are degraded. The partly oxi-
dized PWWs contain biodegradable compounds, usually small
carbon atom number carboxylic acids such as acetic acid, which
are an excellent carbon source for denitrification.
Complex physical, chemical and biological treatment offers a
sustainable and competitive alternative to incineration. In order
to determine a safe treatment method, the appropriate combi-
nation of the aforementioned techniques and the detailed char-
acterization of the PWWs will be needed, including the quan-
tification of their biodegradability when diluted with domestic
wastewater at different ratios.
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Fig. 6. Treatment alternatives of PWWs of pharmaceutical origin
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